RESUMEN
Objective: To observe the clinical efficacy of balancing acupuncture therapy in the treatment of chest pain following lung cancer. Methods: Twenty-four cases of primary bronchial lung cancer with chest pain were treated by balancing acupuncture therapy; the relief of chest pain and its relief time were observed. Results: Among the 24 cases undergoing balancing acupuncture therapy, the chest pain was absolutely relieved in 3 cases, partially relieved in 13 cases, lightly relieved in 4 cases and not relieved in 4 cases; the total response rate was 83.3%. In terms of the relief time, 9 cases responded to the balancing acupuncture therapy in 0-3 min, accounting for 37.5%; 5 cases responded in 4-6 min, accounting for 20.8%; the average responding time was (4.85±1.45) min. Conclusion: Balancing acupuncture therapy is rapid-acting, safe, convenient and inexpensive in the treatment of chest pain following lung cancer.
RESUMEN
Objective:To observe the therapeutic efficacy of puncturing Neiguan (PC 6) and Zusanli (ST 36) on chemotherapy-related nausea and vomiting.Methods: In addition to the routine intervention for vomiting, the 26 malignant cancer patients after the platinum-involved chemotherapy were punctured at bilateral Zusanli (ST 36) and Neiguan (PC 6) twice a day before the chemotherapy lasting until 3 days after the chemotherapy, each treatment lasting 30 min. All the patients were adopted the self-comparison approach, i.e., the needling therapy was used either in the first or the second treatment course.Results:As far as the acupuncture treatment group is concerned, 15 cases got nausea and vomiting, including 6 cases of Ⅰ°, 5 cases of Ⅱ°, 2 cases of Ⅲ° and no reaction of Ⅳ°, 11 cases of acute vomiting, 4 cases of delayed vomiting and no case of premature vomiting; while as far as the control group is concerned, 19 cases got nausea and vomiting, including 5 cases of Ⅰ°, 9 cases of Ⅱ°, 4 cases of Ⅲ° and 1 case of Ⅳ°, 13 cases of acute vomiting, 6 cases of delayed vomiting and no case of premature vomiting. The vomiting occurrence rate and degree in the treatment group were both lower than that of the control group(57.7%vs 73.1%, P＜0.01) and the patients in the treatment group had an improved life quality.Conclusion:Puncturing the bilateral Zusanli (ST 36) and Neiguan (PC 6) can reduce the gastrointestinal reaction to platinum-involved chemotherapy project and improve the patients' life quality.
RESUMEN
Purpose:To study the synergistic inhibitory effects of huachansu plus vinorelbine on cell growth in mice bearing Lewis lung cancer. Methods:Fifty mice bearing Lewis lung cancer were randomly divided into control group,cyclophosphamide group (CTX),huachansu group (HCS), vinorelbine group (VNB) and huachansu plus vinorelbine group (HV). Each group included ten mice. Normal saline (0.2 ml),cyclophosphamide (30 mg/kg),huachansu (5 ml/kg),vinorelbine (6.7 mg/kg),huachansu (5 ml/kg) plus vinorelbine group (6.7mg/kg) were injected intraperitoneally,respectively in the five groups. After the drugs were administered for seven days,all mice were sacrificed and the tumors were weighed. The tumor inhibitory rates were calculated and compared among the five groups of mice. The growth cycles of Lewis lung cancer were analyzed with flow cytometry. Results:The tumor inhibitory rates of HCS,VNB and HV group were 42.86% ,45.68%,53.44%,respectively. The percentage of S phase of cell cycle was increased in HCS and the percentage of G 2 /M phase increased in VNB,and both increased in HV group. Conclusions:There exists synergistic inhibitory effect on Lewis lung cancer between huachansu and vinorelbine and the mechanisms could correlate with their synergistic effect on cell growth cycles.